Centessa Pharmaceuticals (CNTA)

• Market cap: $3.06B
• 1 day: 1.28%
• 5 days: -0.35%
• 1 month: 7.17%
• 3 months: 46.07%
• 6 months: 93.24%
• Year to date: 30.63%
• 1 year: 40.33%
• 5 years: 5.1%
• 10 years: 5.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Employees: 98